The ASAM Pain & Addiction Essentials Online

Don Teater MD, MPH is a family physician who has worked in western North Carolina for the past 30 years. Since 2004 he has focused on the intersection of pain, opioids, and addiction. Don was the lead facilitator for the expert panel during the development of the CDC Guidelines for Prescribing Opioids for Chronic Pain.

From 2013-2016, Don was the Medical Advisor at the National Safety Council leading their effort to reduce opioid abuse and overdose in the community and in the workplace. He continues to work with federal and state government organizations, medical organizations and nonprofits in addressing many aspects of the opioid epidemic.

While working on the public health aspects of the opioid epidemic, he sees patients one day a week treating opioid use disorder and chronic pain in Waynesville, NC by telemedicine. He also works one week each month as a pain and addiction specialist seeing Alaska Native patients with the SouthEast Alaska Regional Health Consortium (SEARHC) in Juneau, AK.

Launette Rieb, MD, MSc, CCFP, FCFP, DABAM, FASAM is a Clinical Associate Professor in the Department of Family Practice at the University of British Columbia (UBC), Canada. She is a Family Physician and diplomat of The American Board of Addiction Medicine. She did her graduate work in the area of pain physiology. She completed a postgraduate UBC Clinical Scholar's Program in 2015 and a NIDA sponsored Canadian Addiction Medicine Research Fellowship in 2016 resulting in publication on a newly described opioid pain phenomenon - withdrawal-associated injury-site pain (WISP). She has also published on fentanyl and heroin overdose deaths in BC, as well as on addiction in a variety of marginalized populations. Dr. Rieb is the Medical Director of a multidisciplinary team at OrionHealth (Vancouver Pain Clinic), and works as a consultant for the Rapid Access Addictions Clinic at St. Paul’s Hospital in Vancouver. In addition, she does addiction medicine consultations for The Orchard Recovery Centre, on Bowen Island. Dr. Rieb has taught addiction medicine in the undergraduate and postgraduate medical programs at UBC, and at national and international conferences for 24 years. Dr. Rieb was the co-creator and initial Physician Director of the St. Paul’s Hospital Goldcorp Addiction Medicine Fellowship (now the BC Centre on Substance Use Addiction Medicine Fellowship). She is a member of the Canadian Society of Addiction Medicine’s Education Committee and the College of Family Physician of Canada's Competency Creation Working Group for the Certificate of Added Competency in Addiction Medicine. Dr. Rieb is the past recipient of a UBC Faculty of Medicine Post Graduate Teaching Award. 

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) where she oversees ASAM’s quality improvement programs, publication development, and science initiative with the goal of supporting effective implementation of evidence based practices in the addiction treatment system.

Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS). 

Dr. Boyle has worked in the areas of  research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), and the National Institute on Drug Abuse (NIDA).  At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment. 

Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan; she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public; and she led development of research reports and other science communication materials. 

Sarah E. Wakeman, MD is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative, program director of the Mass General Addiction Medicine fellowship, and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team, co-chair of the Mass General Opioid Task Force, clinical co-lead of the Partners Healthcare Substance Use Disorder Initiative, and co-chair of the Partners Healthcare Opioid Steering Committee. She is the Chief Medical Officer of RIZE Massachusetts, a state-wide, private sector initiative created to build a $50 million fund to implement and evaluate innovative interventions to address the opioid overdose crisis. 

She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate and fellow of the American Board of Addiction Medicine and board certified in Addiction Medicine by the American Board of Preventive Medicine. She is chair of the policy committee for the Massachusetts Society of Addiction Medicine. She served on Massachusetts' Governor Baker’s Opioid Addiction Working Group. Nationally, she served as chair of the American Society of Addiction Medicine Drug Court Task Force and serves on their Ethics Committee.

Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her research interests include evaluating models for integrated substance use disorder treatment in general medical settings, low threshold treatment models, recovery coaching, physician attitudes and practice related to substance use disorder, and screening for substance use in primary care. 

Anika Alvanzo, MD, MS, DFASAM, FACP is the Eastern Region Medical Director for Pyramid Healthcare, Inc. She also serves as a physician consultant on substance use disorders to the Behavioral Health Administration in the Maryland Department of Health and is the Managing Partner of Uzima Consulting Group, LLC, which provides addiction medicine-related consultation, education and training, and expert witness testimony. Dr. Alvanzo is a graduate of the George Washington University School of Medicine and Health Sciences and holds a master’s degree in biostatistics from Virginia Commonwealth University. She is board certified in Internal Medicine and Addiction Medicine. Dr. Alvanzo is a Distinguished Fellow of ASAM, a Past President of the Maryland-DC Society of Addiction Medicine (MDDCSAM), and currently serves as Chair of the ASAM Annual Conference Program Planning Committee and Region V Director for the ASAM Board of Directors.

At Pyramid Healthcare, Inc., Dr. Alvanzo’s role is to optimize and standardize the medical care, with emphasis on substance withdrawal management and pharmacotherapy, in the residential and outpatient addiction treatment programs in Eastern Pennsylvania and Maryland. Prior to this, Dr. Alvanzo spent twelve years as faculty in the Divisions of General Internal Medicine and Addiction Medicine at Johns Hopkins University School of Medicine where she held a variety of clinical leadership roles, including Associate Medical Director of Addiction Treatment Services and the Center for Addiction and Pregnancy and Medical Director of the Broadway Center for Addiction, comprehensive, outpatient substance use disorder treatment (SUD) programs on the Johns Hopkin Bayview and Johns Hopkins Hospital campuses, respectively. From 2011 – 2018, Dr. Alvanzo directed the Substance Use Disorders Consultation Service, a multidisciplinary addiction consultation service serving the Johns Hopkins Hospital Department of Medicine general and subspecialty services.

Dr. Alvanzo has served as an expert on National Institutes of Health (NIH), Substance Abuse and Mental Health Services Administration (SAMHSA), National Academies of Sciences, Engineering and Medicine (NASEM), National Quality Forum (NQF) and PEW Research Center panels regarding opioids and integration of recovery-oriented care in various medical settings. 

Matt Tierney, APRN is a Nurse Practitioner and a Clinical Professor at the UCSF School of Nursing. He also serves as Clinical Director of Substance Use Treatment and Education for the Office of Population Health at UCSF Health. The focus of his career has been on improving essential addiction treatment delivery locally, regionally, and nationally. He is a Fellow of the American Academy of Nursing, where he serves on the Expert Panel on Psychiatric-Mental Health and Substance Use. Matt is also President-Elect of the American Psychiatric Nurses Association and represents APNA as a sponsoring member of the National Academies of Science Engineering and Medicine's Forum of Mental Health and Substance Use Disorders. He is an ASAM member who has been teaching waiver training courses since 2008. He has treated over 1,600 patients with buprenorphine and has worked in licensed Opiate Treatment programs providing all three FDA-approved medications for OUD treatment.

Olivia Sinaiko, MA, is a behavioral health clinician with the Southeast Alaska Regional Health Consortium (SEARHC) in Juneau, AK. Olivia takes a trauma-informed, client-centered, and social justice-oriented approach to patient care, working with patients of all ages on a broad range of issues. A key focus in her work with clients is Pain Reprocessing Therapy (PRT), a form of therapy designed for patients with chronic pain. She offers a six-week pain neuroscience education program for people with chronic pain, as well as individual PRT therapy. 
 
Olivia graduated Phi Beta Kappa from Stanford University, with a B.A. in Philosophy. After earning a law degree from Yale Law School and completing a clerkship with the Alaska Supreme Court, she realized her true calling in supporting individuals, families, and communities as they navigate difficult transitions. Olivia returned to school for a master’s degree in counseling psychology from The Wright Institute.

Kari is an occupational therapist and Pain Program manager with the Southeast Alaska Regional Health Consortium (SEARHC). Kari is passionate about empowering patients and providers through education and, in addition to her clinical practice, works with occupational therapy education programs and students to promote excellence in the next generation of therapy providers. Kari has clinical interests in rural health care, chronic pain management and hand therapy.  
Kari earned a bachelor of science degree in occupational therapy at Loma Linda University and doctorate in occupational therapy with a certificate in executive leadership at the University of St Augustine for Health Sciences.

Kari is passionate about bringing exceptional care to the residents of rural and remote communities. Kari has 30 years of clinical experience predominantly in rural health care settings as well as regulatory enforcement with the California Department of Public Health, Licensing and Certification Division. 

Dr Rudolf is a physician board certified in addiction medicine, pain medicine, medical acupuncture and family medicine practicing at Swedish Pain Services in Seattle. The clinic integrates multidisciplinary pain care approaches in an effort to optimize patient functional outcomes and self-efficacy. He has also worked extensively in inpatient substance use disorder treatment settings and has published on the topic of opioid withdrawal management. He is the current Chair of the ASAM Pain and Addiction Committee, the immediate past president of the Washington Society of Addiction Medicine, and is a clinical associate professor at University of Washington.

Aram Mardian, M.D. is a clinical associate professor of Family, Community, and Preventive Medicine at the University of Arizona College of Medicine–Phoenix is a board-certified family physician and holds additional certifications in addiction medicine, pain medicine, and medical acupuncture. He is the founding Chief of the Chronic Pain Wellness Center at the Phoenix VA Health Care System, which models interprofessional whole-person care for patients with pain and opioid use disorder.  Dr. Mardian serves as Co-Chair for the Arizona Pain and Addiction Curriculum Workgroup.